GYROSCOPE THERAPEUTICS

gyroscope-therapeutics-logo

Gyroscope is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye. The company explores the convergence of advancements made in the understanding of the complement systemโ€™s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD), and gene therapy as a mode of treatment delivery. Its lead investigational gene therapy, GT005, is a one-time therapy delivered under the retina. GT005 is designed to restore balance to an o... veractive complement system by increasing the production of the Complement Factor I protein. GT005 is currently being evaluated in a Phase I/II clinical trial called FOCUS and Phase II clinical trials called EXPLORE and HORIZON. Andrew Lotery, David Kavanagh, and Peter Lachmann co-founded Gyroscope Therapeutics in Stevenage, Herefordshire in 2016.

#SimilarOrganizations #People #Financial #Website #More

GYROSCOPE THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Health Care Therapeutics

Founded:
2016-01-01

Address:
Stevenage, Herefordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.gyroscopetx.com

Total Employee:
101+

Status:
Active

Contact:
+44 (0)1438 906770

Email Addresses:
[email protected]

Total Funding:
269.52 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

harpoon-therapeutics-logo

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.

northsea-therapeutics-logo

NorthSea Therapeutics

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

regulus-therapeutics-logo

Regulus Therapeutics

Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system


Current Advisors List

maha-katabi_image

Maha Katabi Board Member @ Gyroscope Therapeutics
Board_member
2021-03-01

wouter-joustra_image

Wouter Joustra Board Member @ Gyroscope Therapeutics
Board_member
2021-03-01

chris-hollowood_image

Chris Hollowood Chairman @ Gyroscope Therapeutics
Board_member

not_available_image

Dmitrij Hristodorov Board Observer @ Gyroscope Therapeutics
Board_observer
2021-03-26

Current Employees Featured

andrew-lotery_image

Andrew Lotery
Andrew Lotery Professor of Ophthalmology, University of Southampton, Academic Founder @ Gyroscope Therapeutics
Professor of Ophthalmology, University of Southampton, Academic Founder

peter-lachmann_image

Peter Lachmann
Peter Lachmann Academic Founder @ Gyroscope Therapeutics
Academic Founder

david-kavanagh_image

David Kavanagh
David Kavanagh Professor of Nephrology, Newcastle, Academic Founder @ Gyroscope Therapeutics
Professor of Nephrology, Newcastle, Academic Founder
2008-01-01

khurem-farooq_image

Khurem Farooq
Khurem Farooq Chief Executive Officer @ Gyroscope Therapeutics
Chief Executive Officer
2018-10-01

charlotte-arnold_image

Charlotte Arnold
Charlotte Arnold Vice President, Corporate Affairs @ Gyroscope Therapeutics
Vice President, Corporate Affairs
2020-07-01

edward-lang-jr_image

Edward Lang Jr
Edward Lang Jr Chief Business Officer @ Gyroscope Therapeutics
Chief Business Officer

arman-nadershahi_image

Arman Nadershahi
Arman Nadershahi Senior Director, Associate General Counsel @ Gyroscope Therapeutics
Senior Director, Associate General Counsel
2021-04-01

Founder


andrew-lotery_image

Andrew Lotery

david-kavanagh_image

David Kavanagh

peter-lachmann_image

Peter Lachmann

Acquisitions List

Date Company Article Price
2019-04-11 Orbit Biomedical Orbit Biomedical acquired by Gyroscope Therapeutics N/A

Investors List

sanofi_image

Sanofi

Sanofi investment in Corporate Round - Gyroscope Therapeutics

syncona-partners-llp_image

Syncona Partners LLP

Syncona Partners LLP investment in Series C - Gyroscope Therapeutics

cambridge-innovation-capital_image

Cambridge Innovation Capital

Cambridge Innovation Capital investment in Series C - Gyroscope Therapeutics

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series C - Gyroscope Therapeutics

tetragon-financial-group-limited_image

Tetragon Financial Group Limited

Tetragon Financial Group Limited investment in Series C - Gyroscope Therapeutics

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Series C - Gyroscope Therapeutics

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series C - Gyroscope Therapeutics

fosun-pharmaceutical_image

Fosun Pharma

Fosun Pharma investment in Series C - Gyroscope Therapeutics

cambridge-innovation-capital_image

Cambridge Innovation Capital

Cambridge Innovation Capital investment in Series B - Gyroscope Therapeutics

syncona-partners-llp_image

Syncona Partners LLP

Syncona Partners LLP investment in Series B - Gyroscope Therapeutics

Official Site Inspections

http://www.gyroscopetx.com Semrush global rank: 3.26 M Semrush visits lastest month: 5.05 K

  • Host name: 104.18.27.220
  • IP address: 104.18.27.220
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Gyroscope Therapeutics" on Search Engine